Founded at the Abramson Cancer Center at the University of Pennsylvania

A Phase I trial of pembrolizumad with hypofractionated radiotherapy in patients with metatastic solid tumours

A Phase I trial of pembrolizumad with hypofractionated radiotherapy in patients with metatastic solid tumours

British Journal of Cancer │ 2018

Amit Maity; Rosemarie Mick; Alexander C. Huang; Sangeeth M. George; Michael D. Farwell; John N. Lukens; Abigail T. Berman; Tara C. Mitchell; Josh Baumi; Lynn M. Schuchter; Mark O’Hara; Lillie L. Lin; Angela Demichele; John P. Christodouleas; Naomi B. Haas; Dana M. Patsch; Stephen M. Hahn; Andy J. Minn; E. John Wherry; Robert H. Vonderheide